APA (7th ed.) Citation

Lawless, S., Schönland, S., Sbianchi, J., Morris, C., Iacobelli, S., Bosman, P., . . . Garderet, L. (2021). IgD subtype but not IgM or non-secretory is a prognostic marker for poor survival following atologous hematopoietic cell transplantation in multiple myeloma: Results from the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) study. Clinical lymphoma, myeloma & leukemia, 21(10), . https://doi.org/10.1016/j.clml.2021.05.012

Chicago Style (17th ed.) Citation

Lawless, Sarah, et al. "IgD Subtype but Not IgM or Non-secretory Is a Prognostic Marker for Poor Survival Following Atologous Hematopoietic Cell Transplantation in Multiple Myeloma: Results from the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study." Clinical Lymphoma, Myeloma & Leukemia 21, no. 10 (2021). https://doi.org/10.1016/j.clml.2021.05.012.

MLA (9th ed.) Citation

Lawless, Sarah, et al. "IgD Subtype but Not IgM or Non-secretory Is a Prognostic Marker for Poor Survival Following Atologous Hematopoietic Cell Transplantation in Multiple Myeloma: Results from the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study." Clinical Lymphoma, Myeloma & Leukemia, vol. 21, no. 10, 2021, https://doi.org/10.1016/j.clml.2021.05.012.